Clin2
NCT05853627Possibly a fitRecruiting

Propranolol versus standard therapy for trauma imagery reactions

Stress Disorders, Post-Traumatic

Treatments studied

Part of Mental health clinical trials.

This study tests whether propranolol (a beta-blocker) changed alongside a standard approach can reduce how strongly your body reacts during traumatic imagery. It’s meant for adults who have had a traumatic event and may help lessen fear and stress responses tied to those memories.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You’re between 18 and 65 years old
  • You’ve had a traumatic event and have trauma symptoms on a PTSD checklist (PCL-5 score above 33)
  • During baseline testing with guided traumatic imagery, your body reactions must meet the study’s threshold
  • Your resting blood pressure is at least 90/60 and your resting heart rate is at least 50
  • You can safely take propranolol and have no past bad reaction to beta-blockers

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06215313Enrolling by invitation
Comparing two therapies for trauma memories

This study compares two types of therapy—EMDR and imagery rescripting—to help people who have upsetting memories or nightmares from past events. It's for people with depression or PTSD, and you'll need to come to therapy twice a week.

Eindhoven, North Brabant
NCT02560805Recruiting· Phase 2
Study drugs that affect stress nerves and blood pressure in PTSD

This Phase 2 study looks at how stress-related nerve activity and a hormone called angiotensin II may be involved in PTSD, and how specific blood-pressure-related medicines affect the body. You may be eligible if you are a PTSD patient (or a matched control without PTSD) and meet safety criteria.

Decatur, Georgia
NCT05788302Recruiting
Studying prolonged exposure for PTSD and how it helps

This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.

Boston, Massachusetts
NCT06429293Recruiting
Talk therapy for PTSD and heart health

This study tests whether cognitive behavioral therapy (a type of talk therapy) can improve heart health in people with PTSD. If you have PTSD and are at risk for or have heart disease, you may be able to join.

Boston, Massachusetts
NCT07792122Not yet recruiting· Phase 3
Propranolol for PTSD after violence

This study tests whether propranolol, a medication that may help reduce fear memories, can treat PTSD in women who have experienced violence. Participation involves taking the medication and attending sessions to reactivate traumatic memories.

Montpellier
NCT04985344Recruiting· Phase 3
Propranolol to treat PTSD symptoms in children using memory reactivation

This trial studies whether propranolol (a heart-related medicine) can help children with post-traumatic stress disorder (PTSD) after a special memory-activation session. The goal is to reduce PTSD symptoms compared with the comparison condition.

Toulouse

Hear when a new Stress Disorders, Post-Traumatic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.